MedPath

Piritramide

Generic Name
Piritramide
Drug Type
Small Molecule
Chemical Formula
C27H34N4O
CAS Number
302-41-0
Unique Ingredient Identifier
4RP92LYZ2F

Overview

Piritramide is under investigation for the treatment of Colon Cancer and Minimal Residual Disease. Piritramide has been investigated for the supportive care of Pain, Postoperative and Postoperative Nausea and Vomiting.

Background

Piritramide is under investigation for the treatment of Colon Cancer and Minimal Residual Disease. Piritramide has been investigated for the supportive care of Pain, Postoperative and Postoperative Nausea and Vomiting.

Indication

No indication information available.

Associated Conditions

  • Severe Pain

Clinical Trials

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath